Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐2 as an Adjunct to Antiretroviral Therapy for HIV‐positive Adults." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431575/all/Interleukin‐2_as_an_adjunct_to_antiretroviral_therapy_for_HIV‐positive_adults.
Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431575/all/Interleukin‐2_as_an_adjunct_to_antiretroviral_therapy_for_HIV‐positive_adults. Accessed February 9, 2025.
Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431575/all/Interleukin‐2_as_an_adjunct_to_antiretroviral_therapy_for_HIV‐positive_adults
Interleukin‐2 as an Adjunct to Antiretroviral Therapy for HIV‐positive Adults [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431575/all/Interleukin‐2_as_an_adjunct_to_antiretroviral_therapy_for_HIV‐positive_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults
ID - 431575
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431575/all/Interleukin‐2_as_an_adjunct_to_antiretroviral_therapy_for_HIV‐positive_adults
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -